Rudy Giuliani, 81, opens up about a 'significant' spiritual experience during a coma caused by severe viral pneumonia, saying he has since recovered fully.

A "suspected" hantavirus case is under investigation in New York's Ontario County, with officials saying there is no risk to the general public from it.

Conversation starters, celebrity health reveals, healthy living hacks and medical cautions: Here's what you missed in Fox News Health this week

Low-dose ibuprofen combined with home exercise could help cancer patients manage chemo brain, according to a new University of Rochester study finds.

Amid concerns of hantavirus cases, Dr. Marc Siegel says there is 'no comparison' between hantavirus and COVID-19 pandemic concerns.

An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a study published in Nature.

A clade I mpox case is confirmed in Connecticut as global health officials also monitor newly reported hantavirus cases in Spain and France.

A Dutch hospital quarantined a dozen staff after officials said strict hantavirus protocols were not followed for a patient from a cruise ship outbreak.

Ivermectin prescriptions spiked among cancer patients after Mel Gibson endorsed antiparasitic drugs on Joe Rogan's podcast, a new JAMA study reports.

From sheds to storage units, health experts reveal the everyday places where hantavirus can lurk and how to safely clean rodent-contaminated areas.

MV Hondius cruise ship passenger documents his quarantine experience at a Nebraska medical facility as officials monitor a hantavirus outbreak on board.

The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.

Women's health experts rename PCOS to polyendocrine metabolic ovarian syndrome, or PMOS, in a landmark paper published in The Lancet medical journal.

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers dispute the findings.